Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Breast 1

Conditions

Multiple Myeloma 7Glioma 7Wilms Tumor 6Rhabdoid Tumor 6Osteosarcoma 6Neuroblastoma 6Neoplasm Metastasis 6Leukemia, Myeloid, Acute 6Breast Neoplasms 6Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Lymphoma, Non-Hodgkin 5Lung Neoplasms 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Ependymoma 5Rhabdomyosarcoma 4Prostatic Neoplasms 4Myelodysplastic Syndromes 4Lymphoma 4Central Nervous System Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Sarcoma, Ewing 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1radium Ra 223 dichloride 1pertuzumab 1X-Rays 1Trastuzumab 1Taxoids 1Taxes 1Steroids 1Radiotherapy 1Radiosurgery 1Radiation 1Photons 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Simple 1Mastectomy, Segmental 1Hormones 1High-Energy Shock Waves 1Cyclin-Dependent Kinase Inhibitor p18 1Cyclin-Dependent Kinase Inhibitor p16 1CT-P6 1Biopsy 1Ado-Trastuzumab Emtansine 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage IV Breast Cancer AJCC v8 × X-Rays × 30 days × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡